Search Results - "Kazantsev, Aleksey G."

Refine Results
  1. 1

    Therapeutic application of histone deacetylase inhibitors for central nervous system disorders by Kazantsev, Aleksey G, Thompson, Leslie M

    Published in Nature reviews. Drug discovery (01-10-2008)
    “…Key Points This Review focuses on the family of histone deacetylases (HDACs) and their regulatory roles in cells with specific application to neurons. It…”
    Get full text
    Journal Article
  2. 2

    Sirtuins in Alzheimer's Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics by Cacabelos, Ramón, Carril, Juan C, Cacabelos, Natalia, Kazantsev, Aleksey G, Vostrov, Alex V, Corzo, Lola, Cacabelos, Pablo, Goldgaber, Dmitry

    “…Sirtuins (SIRT1-7) are NAD⁺-dependent protein deacetylases/ADP ribosyltransferases with important roles in chromatin silencing, cell cycle regulation, cellular…”
    Get full text
    Journal Article
  3. 3

    The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models by Chopra, Vanita, Quinti, Luisa, Kim, Jinho, Vollor, Lorraine, Narayanan, K. Lakshmi, Edgerly, Christina, Cipicchio, Patricia M., Lauver, Molly A., Choi, Soo Hyuk, Silverman, Richard B., Ferrante, Robert J., Hersch, Steven, Kazantsev, Aleksey G.

    Published in Cell reports (Cambridge) (27-12-2012)
    “…Inhibition of sirtuin 2 (SIRT2) deacetylase mediates protective effects in cell and invertebrate models of Parkinson’s disease and Huntington’s disease (HD)…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    SIRT2 as a Therapeutic Target for Age-Related Disorders by de Oliveira, Rita Machado, Sarkander, Jana, Kazantsev, Aleksey G, Outeiro, Tiago Fleming

    Published in Frontiers in pharmacology (01-01-2012)
    “…Sirtuin proteins are conserved regulators of aging that have recently emerged as important modifiers of several diseases which commonly occur later in life…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    The role of Nrf2 signaling in counteracting neurodegenerative diseases by Dinkova‐Kostova, Albena T., Kostov, Rumen V., Kazantsev, Aleksey G.

    Published in The FEBS journal (01-10-2018)
    “…The transcription factor Nrf2 (nuclear factor‐erythroid 2 p45‐related factor 2) functions at the interface of cellular redox and intermediary metabolism. Nrf2…”
    Get full text
    Journal Article
  12. 12

    Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia by Spires-Jones, Tara L, Fox, Leora M, Rozkalne, Anete, Pitstick, Rose, Carlson, George A, Kazantsev, Aleksey G

    Published in Frontiers in pharmacology (01-01-2012)
    “…Tauopathies including tau-associated Frontotemporal dementia (FTD) and Alzheimer's disease are characterized pathologically by the formation of tau-containing…”
    Get full text
    Journal Article
  13. 13

    Identification of Tri- and Tetracyclic Pyrimidinediones as Sirtuin Inhibitors by Rotili, Dante, Tarantino, Domenico, Carafa, Vincenzo, Lara, Ester, Meade, Sarah, Botta, Giorgia, Nebbioso, Angela, Schemies, Jörg, Jung, Manfred, Kazantsev, AlekseyG., Esteller, Manel, Fraga, Mario F., Altucci, Lucia, Mai, Antonello

    Published in ChemMedChem (03-05-2010)
    “…Sirtuins are deacetylase proteins that regulate transcription, genome maintenance, longevity, and metabolism. Eight compounds were identified as a novel class…”
    Get full text
    Journal Article
  14. 14

    Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators by Rigamonti, Dorotea, Bolognini, Daniele, Mutti, Cesare, Zuccato, Chiara, Tartari, Marzia, Sola, Francesco, Valenza, Marta, Kazantsev, Aleksey G., Cattaneo, Elena

    Published in The Journal of biological chemistry (24-08-2007)
    “…Increased levels of the repressor element 1/neuron restrictive silencer element (RE1/NRSE) silencing activity promoter, and a consequent reduction in the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    New Directions for Neurodegenerative Disease Therapy: Using Chemical Compounds to Boost the Formation of Mutant Protein Inclusions by Bodner, Ruth A., Housman, David E., Kazantsev, Aleksey G.

    Published in Cell cycle (Georgetown, Tex.) (15-07-2006)
    “…Neurodegenerative disease such as Huntington's, Parkinson's, and Alzheimer'sdiseases are marked by neuronal accumulation of toxic misfolded protein…”
    Get full text
    Journal Article
  17. 17
  18. 18

    RNA Interference-Mediated Silencing of Mutant Superoxide Dismutase Rescues Cyclosporin A-Induced Death in Cultured Neuroblastoma Cells by Maxwell, Michele M., Pasinelli, Piera, Kazantsev, Aleksey G., Brown, Robert H., Housman, David E.

    “…Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disorder resulting from selective death of motor neurons in the brain and…”
    Get full text
    Journal Article
  19. 19

    The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS by Maxwell, Michele M., Tomkinson, Elizabeth M., Nobles, Johnathan, Wizeman, John W., Amore, Allison M., Quinti, Luisa, Chopra, Vanita, Hersch, Steven M., Kazantsev, Aleksey G.

    Published in Human molecular genetics (15-10-2011)
    “…Sirtuin 2 (SIRT2) is one of seven known mammalian protein deacetylases homologous to the yeast master lifespan regulator Sir2. In recent years, the sirtuin…”
    Get full text
    Journal Article
  20. 20

    Huntington's disease: From molecular basis to therapeutic advances by Krobitsch, Sylvia, Kazantsev, Aleksey G.

    “…Huntington's disease is an autosomal dominant genetic neurodegenerative disorder, which is characterized by progressive motor dysfunction, emotional…”
    Get full text
    Journal Article